The Joint Corp.
NNASDAQ:JYNTCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Sanjiv Razdan
- Full Time Employees
- 330
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 16767 North Perimeter Drive Scottsdale AZ United States 85260
- IPO Date
- Nov 10, 2014
- CIK
- 0001612630
- Website
- thejoint.com
- Similar Companies
- Business
- The Joint Corp. operates as a leading franchisor in the chiropractic care industry, primarily providing accessible chiropractic services through its The Joint Chiropractic® network. The company specializes in franchise development, management, and support for chiropractic clinics that offer services including chiropractic adjustments, pain relief treatments, wellness care, pain management, sports injury management, and preventive health care. It operates over 950 locations across the United States, servicing more than 14 million patient visits annually. Founded in 2010 and headquartered in Scottsdale, Arizona, The Joint Corp. focuses on an asset-light model emphasizing franchising over corporate ownership of clinics. In recent developments, The Joint Corp. is undertaking a strategic transformation to become a pure-play franchisor by refranchising a majority of its corporate-owned clinics. In 2024 and 2025, it engaged Capstone Partners to accelerate refranchising efforts, aiming to optimize franchisee quality and expand franchise ownership. The company also launched a new mobile app available on iOS and Android platforms to enhance customer engagement. Furthermore, The Joint Corp. authorized a $12 million extension to its stock repurchase program in late 2025, following an initial $5 million tranche, reflecting a focus on capital discipline and shareholder value. It also announced a restatement of financials to correct previous impairment charge calculations, resulting in improved reported net income figures. The company has introduced a new brand awareness campaign in 2025, “Life Unpaused,” emphasizing wellness and ongoing patient engagement. Additionally, The Joint debuted a new clinic location in Delaware, continuing its geographic expansion within the U.S. market. The Joint Corp. serves diverse customer segments, including individuals seeking routine chiropractic care, wellness services, and pain management solutions. Its primary geographic footprint spans the United States, with a focus on regions suitable for retail chiropractic clinic franchising. As the nation’s largest chiropractic franchisor, the company is distinguished by its convenience-oriented business model and broad network reach. The organizational structure supports franchisees with training, marketing, and operational systems, underpinning its growth strategy and enhancing system-wide sales and profitability. Overall, The Joint Corp. is positioned within the healthcare services industry under chiropractic care and franchising business segments, combining healthcare delivery with a scalable franchise platform focused on growth through strategic refranchising and digital engagement. The company’s financial and operational adjustments reflect an emphasis on long-term stability, profitability, and shareholder returns. This description reflects the company’s latest operational, financial, and strategic developments through 2025.
Company News
The Joint Corp. (JYNT) Q3 2026 Earnings Call Transcript
Joint Q3 Earnings Call Highlights
The Joint Corp. (JYNT) Misses Q3 Earnings and Revenue Estimates
The Joint Corp. Reports Third Quarter 2026 Financial Results
Perma-Pipe Expands Coating Capabilities in India Through Majority-Owned Joint Venture with Welspun
Foremost Announces Formation of GR and Blackwing Joint Ventures and Issuance of Warrants to Denison at a Significant Premium
New Joint Survey from Compass Pathways and the Depression and Bipolar Support Alliance Reveals the Lived Burden of Treatment-Resistant Depression on Patients and Caregivers
Co-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE® Test
Tibooburra Project Update: RC drilling to commence as Novo forms unincorporated Joint Venture with Manhattan Gold
49North Signs MOU with UNWAVE for Joint Production and Support of Counter-UAS Systems
Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India
Lionsgate and Steven Paul's SP Media Launch New Joint Venture
E-Power's Guizhou Joint Venture Receives RMB 110 Million of RMB 200 Million Capital Increase at RMB 2.0 Billion Post-Money Valuation
Foremost to Form Joint Ventures with Denison for GR and Blackwing Properties and to Issue Warrants at a Significant Premium
The Joint Corp. to Report 2026 Third Quarter Results on Thursday, November 5 and Host Conference Call and Webcast
Head-To-Head Review: RadNet (NASDAQ:RDNT) vs. Joint (NASDAQ:JYNT)
Vornado, Ken Griffin and Rudin Close Joint Venture, 1.05 Million SF Anchor Lease and $3.3 Billion Construction Loan
Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
Yuchai and Guangxi Zhenye Form New Joint Venture
AST SpaceMobile Rises 4% as Europe's Largest Carriers Explore Joint Satellite Spectrum Bid; SpaceX and Rocket Lab Edge Higher